September 22nd is World CML Day. This day helps to broaden awareness and understanding of chronic myelogenous leukemia (CML), a form of blood cancer that affects approximately 5,000 Canadians. In most cases, CML is caused by a mutation affecting chromosomes 22 and 9. So the date – 22/9 – has become a powerful symbol as the worldwide community unites to raise awareness about the disease and the lives it affects.
Over the last 60 years, there have been significant advancements in CML, both in terms of diagnostics and treatment. Back in 1955, the average survival rate for patients with CML was just 2-3 years. Advancements in the 1960’s and 1970’s led to the discovery that CML was caused by a specific genetic defect, and that bone marrow transplant might provide some with a cure.
Throughout the 1980’s, 1990’s and 2000’s, medications were tested and brought to market, delivering better results and gradually improving survival rates. Today, CML mortality is 70% lower than in 1994. New medications and treatments are helping people with CML live longer, with a better quality of life.
CML-IQ has chronicled the history of CML Advancements in a new infographic. Please feel free to download, print and share this file to help raise awareness of CML across the globe.